Chetan Bettegowda

Johns Hopkins University — United States

Medicine · Health Sciences

68h-index31.6kcitations730works3.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(185), Cancer Genomics and Diagnostics(127), Management of metastatic bone disease(74), Brain Metastases and Treatment(73), Pancreatic and Hepatic Oncology Research(65)

Publications720 total

Data‐Driven Feedback Identifies Focused Ultrasound Exposure Regimens for Improved Nanotheranostic Targeting of the Brain
Advanced Science·2026Open Access
TRBC2-targeting antibody–drug conjugates for the treatment of T cell cancers
Nature Cancer·2025· 1 cited
Figure S9 from The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer
2025Open Access
Figure S2 from The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer
2025Open Access
Figure S7 from The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer
2025Open Access
Supplementary Tables S1 and S2 from The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer
2025Open Access
Brain metastases from renal cell carcinoma: a large retrospective claims-based oncology cohort analysis of prevalence, chronicity, and survival outcomes
Journal of Neuro-Oncology·2025
Figure S5 from The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer
2025Open Access
Figure S10 from The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer
2025Open Access
Figure S4 from The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer
2025Open Access
Figure S8 from The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer
2025Open Access
Figure S3 from The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer
2025Open Access
Figure S1 from The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer
2025Open Access
Supplementary Notes 1-5 from The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer
2025Open Access
Figure S6 from The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer
2025Open Access
Engineering immunotoxin-equipped effector cells and evaluation in primary human immune cells
2025Open Access
Molecular Evidence of Multiorgan Damage in Patients with Immune-Related Adverse Events
New England Journal of Medicine·2025Open Access
Supplementary Table S1 from Dying To Find Out: The Cost of Time at the Dawn of the Multicancer Early Detection Era
2025Open Access
A mouse model of classical trigeminal neuralgia via intradural compression of the trigeminal nerve
2025Open Access
Association Between Nutritional Status and Survival in Patients Requiring Treatment for Spinal Metastases
Neurosurgery·2025Open Access
page 1 of 36Next →

Frequent Co-authors

Bert Vogelstein(33), Kenneth W. Kinzler(31), Nickolas Papadopoulos(23), Nishant Agrawal(19), Shibin Zhou(16), Luis A. Díaz(14), Ralph H. Hruban(11), Victor E. Velculescu(9), Yuxuan Wang(8), Yuchen Jiao(8), Ian Cheong(8), Gary L. Gallia(7), Suely Kazue Nagahashi Marie(7), Gregory J. Riggins(7), Laura D. Wood(7), Mark Sausen(6), Michael Lim(6), Sueli Mieko Oba‐Shinjo(6), George I. Jallo(6), Roger E. McLendon(6)